"\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 11 \u0431\u0435\u0440\u0435\u0437\u043D\u044F 2019"@uk . "High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial"@nl . . . . . "Arthur R Bradwell" . "High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial"@en . . "wetenschappelijk artikel"@nl . . . "10.1016/S2352-3026(19)30014-6" . "article scientifique publi\u00E9 en 2019"@fr . . . "High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial"@en . . . . . . . . . . . . . "Mark D Jesky" . . . . . . . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en marzu de 2019"@ast . . . . "2019-03-11T00:00:00Z"^^ . . . . . . . . "6" . . . . . . "High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial"@nl . "scientific article published on 11 March 2019"@en . . . . . . "30872075" . . . "Paul Cockwell" . . . . . "High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial"@en . . "Nils Heyne" . . "2019 \u0569\u057E\u0561\u056F\u0561\u0576\u056B \u0574\u0561\u0580\u057F\u056B 11-\u056B\u0576 \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E \u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E"@hy . . . . "Julie Wessels" . "Veronica Moroz" . . . . . . . . . . . . . "Markus Storr" . . . . . . . . . . . . . "Julian D Gillmore" . "High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial"@en . "Lesley Fifer" . . . . "Colin A Hutchison" . "4" . "Christopher G Winearls" . . . "im M\u00E4rz 2019 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . "e217-e228" . . . "High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial"@nl .